Creative Biolabs leverages extensive experience and cutting-edge research methods to offer tailored antibody development services that meet the unique needs of each client. With world-leading technology platforms and professional expertise, we specialize in developing monoclonal antibodies that target specific microbial components within the human microbiome, supporting research into novel therapies against diverse pathogens and diseases. Our comprehensive services encompass all stages of antibody drug development, including target identification and validation, hit identification, hit-to-lead, lead optimization, and IND-enabling.
